MicroPort CardioFlow Medtech Corp (HKSE:02160) Share Price

Company Profile

Business description
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China. The Group derives revenue from the sales of medical devices through appointed distributors. It derives maximum revenue from PRC.
Contact
No. 1601 Zhangdong Road
Zhangjiang Hi-Tech Park
Pudong New District
Shanghai201203
CHN
T: +86 2138954600
https://www.cardioflowmedtech.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
417

Recommended

Wide moat Eli Lilly receives FDA approval for obesity pill.

Karen Andersen, CFA | 02 April 2026

These companies are our favourite choices for investors wanting to boost Aussie equity exposure.

Simonelle Mody | 02 April 2026

OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.

Harrison Rolfes | 02 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,786.70	113.00	-1.27%
CAC 40	7,981.27	164.33	2.10%
DAX 40	23,298.89	618.85	2.73%
Dow JONES (US)	46,565.74	224.23	0.48%
FTSE 100	10,364.79	188.34	1.85%
HKSE	25,058.08	235.95	-0.93%
NASDAQ	21,840.95	250.32	1.16%
Nikkei 225	52,731.94	1,007.74	-1.88%
NZX 50 Index	12,881.17	55.30	0.43%
S&P 500	6,575.32	46.80	0.72%
S&P/ASX 200	8,590.40	94.60	-1.09%
SSE Composite Index	3,926.64	21.91	-0.55%